Identifying, financing and accompanying the future leaders of tomorrow
€690m
Under mgmt
150
exits and 26 IPO
Our successes
Life Sciences
- Microbiome / Nutrition / Foodtech / Lifestyle
- Connected Health & Food / Wellness
- Biotech & Pharmaceuticals
- Medtech & Diagnosis
- Industrial Biotech
Digital Technologies
- Fintech
- Saas Software Editor
- Innovative Services
- Infrastructure Technologies
News
-
16 October 2018LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University
Read more...LNC aims to develop the first Christensenella-based drug...
-
10 October 2018Our Responsible Investment Annual Report is available online
Click to upload our Responsible Investment Report
-
4 October 2018Vedanta Biosciences Announces Successful Phase 1a/1b Data Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead, Rationally Defined Bacterial Consortium Product Candidate, VE303
Read more...Vedanta Biosciences, a clinical-stage company developing...
-
1 October 2018
LNC Therapeutics launches a new clinical trial, OBEMINALE 2, and treats its first patient
Read more...LNC Therapeutics, a French biotech company specialized...
-
12 September 2018Launchmetrics raises $50M to continue its rapid growth
Read more...The leading marketing platform and analytics solution...
Events
-
25 September
France Digitale Day, Paris
Come & meet us !
-
04 October
Fintech Tour – 4 October 2018 – MARSEILLE
Come & meet us ! http://bit.ly/2Ck2iBo
-
29 January
Microbiome Drug Development Summit – Paris, 29-31 January
Come & meet us !